Acute Kidney Injury in Patients With CoVID-19

Overview

We aimed to investigate the effect of Acute Kidney Injury (AKİ) on the prognosis of patients hospitalised for COVID-19.

Full Title of Study: “The Effect of Acute Kidney Injury on Prognosis in Patients Hospitalised for COVID-19.”

Study Type

  • Study Type: Observational
  • Study Design
    • Time Perspective: Retrospective
  • Study Primary Completion Date: November 20, 2020

Detailed Description

The effect of Acute Kidney Injury (AKİ) on the prognosis of patients hospitalised for COVID-19. Patients hospitalised for COVID-19 and acute kidney injury will be enrolled. The duration of hospitalisation, mortality rates will be compared in COVID-19 patients with and without acute kidney injury.

Interventions

  • Other: duration of hospitalization, mortality rate
    • duration of hospitalization, mortality rates of patients hospitalised for COVID-19 evaluated and compared in patients with and without acute kidney injury.

Arms, Groups and Cohorts

  • COVID-19 patients with acute kidney injury
    • COVID-19 patients with acute kidney injury
  • COVID-19 patients without acute kidney injury
    • COVID-19 patients without acute kidney injury

Clinical Trial Outcome Measures

Primary Measures

  • mortality rate
    • Time Frame: 6 months
    • mortality rates of COVID-19 patients with and without Acute Kidney Injury
  • duration of hospitalisation
    • Time Frame: 6 months
    • time between admission to hospital and discharge for COVID-19 patients with and without Acute Kidney Injury

Participating in This Clinical Trial

Inclusion Criteria

  • Patients hospitalised with COVID-19. – Patients hospitalised with COVID-19 with Acute Kidney Injury Exclusion Criteria:

-

Gender Eligibility: All

Minimum Age: 18 Years

Maximum Age: 80 Years

Investigator Details

  • Lead Sponsor
    • Uşak University
  • Provider of Information About this Clinical Study
    • Principal Investigator: Zelal Adibelli, Asistant Professor – Uşak University
  • Overall Official(s)
    • Zelal Adibelli, Principal Investigator, Uşak University

Clinical trials entries are delivered from the US National Institutes of Health and are not reviewed separately by this site. Please see the identifier information above for retrieving further details from the government database.

At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.